4//SEC Filing
NxStage Medical, Inc. 4
Accession 0001246360-17-001251
CIK 0001333170operating
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:42 PM ET
Size
8.7 KB
Accession
0001246360-17-001251
Insider Transaction Report
Form 4
Brown Robert S.
Sr. Vice President, CFO
Transactions
- Exercise/Conversion
Common Stock
2017-03-07$16.66/sh+20,000$333,200→ 36,086 total - Sale
Common Stock
2017-03-07$27.75/sh−20,000$555,000→ 16,086 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-03-07−20,000→ 45,618 totalExercise: $16.66From: 2015-04-03Exp: 2025-03-02→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2016.
- [F2]This represents the weighted average price for shares sold in multiple transactions at prices ranging from $27.62 to $27.87, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333170
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:42 PM ET
- Size
- 8.7 KB